Resource Logo
New York Times

Thinner Syringes May Reduce Risk of H.I.V.


A study suggests encouraging drug abusers to use thin syringes, which retain less fluid and the virus it may contain.

Distributing "low-dead-space syringes" to addicts could substantially lessen H.I.V. transmission among them, a new study has estimated.

Syringes have widely varying amounts of "dead space" - the amount of fluid retained even when the plunger is fully depressed, said William A. Zule, a researcher at RTI International and the lead author of the paper in The International Journal of Drug Policy.

Fat ones with interchangeable needles may have 40 times as much dead space as thin ones like those used by diabetics. And simulations of the way addicts draw in blood and rinse with water showed that the biggest syringes can retain 1,000 times as much virus as thinner ones.

Many foreign governments that distribute syringes ignore dead space and buy whatever is cheapest, Dr. Zule said.

Recipients of clean syringes are not supposed to share them, but some do. Users of heroin, cocaine or methamphetamine usually accept thin syringes, the study said. Users of poppy straw extract, homemade stimulants or crushed tablets may not.

The best way to get addicts to demand low-dead-space syringes, Dr. Zule suggested, may be to point out that they get more drug.

"That may not be politically correct, but you need messages that speak to the group you have to work with," he said.

No human clinical trials have proved that such syringes save lives, but the idea is plausible and switching now would be affordable and safe, Dr. Zule argued. 


Copyright © 2013 -New York Times, Publisher. All rights reserved to New York Times company. All New York Times articles contained on the AEGiS web site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of The New York Times Company. You may not alter or remove any trademark, copyright or other notice from copies of the content. However, you may download articles (one machine readable copy and one print copy per page) for your personal, noncommercial use only.

Information in this article was accurate in January 21, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.